Patent · US Active

Formulations, salts and polymorphs of transnorsertraline and uses thereof

US8957114B2 · kind B2 · utility

1Cited by

3References

8Claims

0Family size

Assignee

Sunovion Pharmaceuticals Inc. · US

Inventors

Sharon M. Laughlin · Phoenixville, US
Michael J. Sizensky · Grafton, US
Surendra Singh · Shrewsbury, US
Harold Scott Wilkinson · Westborough, US
Cai Gu Huang · 流花街道, CN
Philip James Bonasia · Needham, US
Susan S. D'Souza · Marlborough, US

Key dates

Filing date	Dec 3, 2010
Grant date	Feb 17, 2015
Priority date	—
Expiry date	Feb 1, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C211/42
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are pharmaceutical compositions comprising transnorsertraline, salts and polymorphic forms of transnorsertraline, methods of making the compositions, and methods for their use for the treatment of CNS diseases, including depression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.